Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Kineret (anakinra) for the Treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID)

Drug Name (Brand / Generic)

Kineret / anakinra

Company / Licensee

Swedish Orphan Biovitrum (Sobi) / Savient Pharmaceuticals

Therapy Class

Recombinant protein drug

Current Indication

Neonatal-onset multisystem inflammatory disease (NOMID) and Rheumatoid Arthritis (RA)

Market Sector

Genetics

Development Status

Approved in the US
Expand

Go Top